Glaukos' Q4 preliminary sales rise 36%, beat estimates
Overview
Ophthalmic pharma firm's preliminary Q4 net sales rose 36%, beating analyst expectations
Company ended Q4 with $283 mln in cash and no debt
Outlook
Glaukos reaffirms 2026 revenue guidance of $600 mln to $620 mln
Company expects sustained growth momentum due to novel technology pipeline
Result Drivers
IDOSE TR SALES - iDose TR contributed $45 mln to U.S. Glaucoma net sales in Q4, highlighting its strong market performance
CORNEAL HEALTH SALES - Corneal Health net sales reached $24 mln in Q4, contributing to overall sales growth
INTERNATIONAL GROWTH - International Glaucoma net sales were $33 mln in Q4, supporting global sales increase
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Sales | Beat | $143 mln | $131.20 mln (14 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 14 "strong buy" or "buy", 1 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Glaukos Corp is $127.50, about 15% above its January 12 closing price of $110.91
Press Release: ID:nBwb0Y99a
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
Related Articles
Coca Cola (KO) Q4 Earnings Preview: Look for the Upside in the AI Initiatives, not in the Revenue and the EPS
Coca-Cola (KO) enters its fourth-quarter 2025 earnings call tomorrow with significant momentum. However, a fundamental shift is occurring.
Warsh’s Fed Era Signals a Death Knell for QE, Jolting the $30 Trillion Treasury Market
With Warsh’s nomination, his past proposals for governing the Federal Reserve are being brought to the forefront. A central issue is the formulation of a new "1951 Accord" to restructure the relationship between the Fed and the Treasury. Analysts suggest such a move could impact the $30 trillion Tre
Amazon Stock Predictions for 2026 to 2030: Will They Exceed Expectations and Achieve Major Long-Term Goals?
TradingKey - As we head into 2026, many investors are questioning where Amazon (AMZN) fits into the technology world.
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
